Výsledky vyhledávání - "Deborah Lafond"

Impact of Pediatric Primary Palliative Care Education and Mentoring in Practice

Autor: Deborah, Lafond, Kathy, Perko, Deborah, Fisher, Laila A, Mahmood, Pamela S, Hinds

Publikováno v: Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association. 24(1)

Primary palliative care education and mentoring strengthens frontline clinicians' confidence and competence in pediatric palliative care, and potentially mitigates their moral distress. The project aims were to improve the knowledge, attitudes, and s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2cdf96feebc97c339964af4e702129c1
https://pubmed.ncbi.nlm.nih.gov/34550914

Zobrazit plný text záznamu

NURS-10. IMPACT OF INTEGRATING PALLIATIVE CARE INTO A NEURO-ONCOLOGY CLINIC

Autor: Lauren Hancock, Deborah Lafond

Publikováno v: Neuro-Oncology. 20:i152-i153

BACKGROUND: CNS tumors account for 25% of cancer deaths in children, in the United States. Children have significant morbidities related to treatment. Palliative care (PC) mitigates symptom distress. METHODS: Three members of the neuro-oncology (NO)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b95af40de959387b3a121b1abd857e78
https://doi.org/10.1093/neuonc/noy059.559

Zobrazit plný text záznamu

High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702)

Autor: Violet Shen, H. Stacy Nicholson, Sharon Gardner, Jonathan L. Finlay, Deborah Lafond, Mehmet Kocak, Roger J. Packer, James M. Boyett, Kellie J. Nazemi

Publikováno v: Pediatric bloodcancer. 63(9)

Background The outcomes with high-risk central nervous system (CNS) embryonal tumors remain relatively poor despite aggressive treatment. The purposes of this study using postirradiation myeloablative chemotherapy with autologous hematopoietic stem c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36c0a1df3c57b262795baca695e948b7
https://pubmed.ncbi.nlm.nih.gov/27203542

Zobrazit plný text záznamu

Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

Autor: Peter C. Burger, Lucy B. Rorke-Adams, Deborah Lafond, Richard Sposto, Lisa Bayer, Roger J. Packer, James Langston, Bernadine Donahue, Karin M. Muraszko, Mary Anne H. Marymont, Patricia L. Robertson, Amar Gajjar, Gilbert Vezina

Publikováno v: Journal of Clinical Oncology. 24:4202-4208

Purpose To determine the event-free survival (EFS) and overall survival of children with average-risk medulloblastoma and treated with reduced-dose craniospinal radiotherapy (CSRT) and one of two postradiotherapy chemotherapies. Methods Four hundred

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51ce70dff7e92bd4c7ab8eb18bd23874
https://doi.org/10.1200/jco.2006.06.4980

Zobrazit plný text záznamu

Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012

Autor: Peter C. Phillips, Deborah Lafond, James M. Boyett, Mark W. Kieran, Mehmet Kocak, Stewart Goldman, Clinton F. Stewart, Tobey J. MacDonald, Larry E. Kun, Richard G. Ellenbogen, Tina Young Poussaint

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(6)

Purpose A phase I trial of the antiangiogenesis agent cilengitide (EMD 121974), an alpha v beta 3,5 integrin antagonist, was performed to estimate the maximum-tolerated dose (MTD) and describe dose-limiting toxicities (DLTs) and the incidence and sev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44ad63fd2e0badaf544b1ca9eefd3c92
https://pubmed.ncbi.nlm.nih.gov/18281665

Zobrazit plný text záznamu

Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20(16)

PURPOSE: This Children’s Cancer Group group-wide phase II trial evaluated the efficacy and toxicity of two chemotherapy arms administered before hyperfractionated external-beam radiotherapy (HFEBRT). PATIENTS AND METHODS: Thirty-two patients with n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::232ceca74fd687008ac0cd8166cada49
https://pubmed.ncbi.nlm.nih.gov/12177103

Zobrazit plný text záznamu

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy

Autor: Roger J. Packer, Leslie N. Sutton, Roy Elterman, Beverly Lange, Joel Goldwein, H. Stacy Nicholson, Lynn Mulne, James Boyett, Giulio D'Angio, Kaethe Wechsler-Jentzsch, Gregory Reaman, Bruce H. Cohen, Derek A. Bruce, Lucy B. Rorke, Patricia Molloy, Janise Ryan, Deborah LaFond, Audrey E. Evans, Luis Schut

Publikováno v: Journal of neurosurgery. 81(5)

✓ It has previously been reported in a single-institution trial that progression-free survival of children with medulloblastoma treated with radiotherapy and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU), cisplatin, and vincristine chemothera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c76e33730f4f67aadefdad1acd4e11ca
https://pubmed.ncbi.nlm.nih.gov/7931615

Zobrazit plný text záznamu

Outcome for children ≤3 years of age with malignant brain or spinal cord tumors treated with high dose chemotherapy with peripheral blood stem cell rescue

Autor: E. Perez, Tobey J. MacDonald, Roger J. Packer, Naynesh Kamani, Deborah Lafond, B. Loechelt, B. Rood, H. K. Thorarinsdottir

Publikováno v: Journal of Clinical Oncology. 23:8552-8552

8552 Background: Children ≤3 years of age (yo) with malignant brain tumors have a dismal prognosis. In a POG study starting in 1986 (NEJM Jun ’93), 102 patients had a 1 and 2 year progression free ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::918a5c7294b98e6da140fc6d354cf4b6
https://doi.org/10.1200/jco.2005.23.16_suppl.8552

Zobrazit plný text záznamu

Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector--producer cells followed by intravenous ganciclovir administration

Autor: Stefan E. Burdach, Jörg-Christian Tonn, Cory Raffel, Philip H. Cogen, Deborah LaFond, Gilbert Vezina, Roger J. Packer, Judith G. Villablanca, J. Gordon McComb, Klaus Burger, Leonard P. Kapcala

Publikováno v: Neurosurgical Focus. 7:E2

Object The outcome for children with recurrent malignant brain tumors is poor. The majority of patients die of progressive disease within months of relapse, and other therapeutic options are needed. The goal of this Phase I study was to evaluate the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2e9937508ed12bfb06c142736534db71
https://doi.org/10.3171/foc.1999.7.6.2

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání